Search research articles
Contact Us
Filters
Showing results (351-360 of 380) with videos related to
Page
of 38
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia
R Bassan, A Z Rohatiner, T Lerede, et al.
Leukemia
|
May 24, 2016
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
C N Harrison, A M Vannucchi, J-J Kiladjian, et al.
Blood
|
March 9, 2000
Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO)
A Bacigalupo, B Bruno, P Saracco, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
June 26, 2001
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups
R Bassan, E Pogliani, P Casula, et al.
Leukemia
|
February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S Koschmieder, T I Mughal, H C Hasselbalch, et al.
Leukemia
|
September 20, 2011
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria
G Finazzi, A Carobbio, J Thiele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma
U Vitolo, S Cortellazzo, A M Liberati, et al.
The American Journal of Medicine
|
May 1, 1996
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry
G Finazzi, V Brancaccio, M Moia, et al.
Frontiers in Cardiovascular Medicine
|
December 15, 2023
Clinical variables associated with late-onset thrombotic and cardiovascular events, after SARS-CoV-2 infection, in a cohort of patients from the first epidemic wave: an 18-month analysis on the "Surviving-COVID" cohort from Bergamo, Italy
S V Benatti, S Venturelli, G Crotti, et al.
Haematologica
|
January 1, 1997
Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO)
I Majolino, A M Cavallaro, A Bacigalupo, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 380) with videos related to
Sort By:
Page
of 38
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia
R Bassan, A Z Rohatiner, T Lerede, et al.
Leukemia
|
May 24, 2016
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
C N Harrison, A M Vannucchi, J-J Kiladjian, et al.
Blood
|
March 9, 2000
Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO)
A Bacigalupo, B Bruno, P Saracco, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
June 26, 2001
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups
R Bassan, E Pogliani, P Casula, et al.
Leukemia
|
February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S Koschmieder, T I Mughal, H C Hasselbalch, et al.
Leukemia
|
September 20, 2011
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria
G Finazzi, A Carobbio, J Thiele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma
U Vitolo, S Cortellazzo, A M Liberati, et al.
The American Journal of Medicine
|
May 1, 1996
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry
G Finazzi, V Brancaccio, M Moia, et al.
Frontiers in Cardiovascular Medicine
|
December 15, 2023
Clinical variables associated with late-onset thrombotic and cardiovascular events, after SARS-CoV-2 infection, in a cohort of patients from the first epidemic wave: an 18-month analysis on the "Surviving-COVID" cohort from Bergamo, Italy
S V Benatti, S Venturelli, G Crotti, et al.
Haematologica
|
January 1, 1997
Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO)
I Majolino, A M Cavallaro, A Bacigalupo, et al.
Page
of 38